Page last updated: 2024-08-26

arginyl-glycyl-aspartic acid and Diabetic Glomerulosclerosis

arginyl-glycyl-aspartic acid has been researched along with Diabetic Glomerulosclerosis in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Gondaliya, P; Jogi, H; Kalia, K; Raval, N; Tekade, RK1

Other Studies

1 other study(ies) available for arginyl-glycyl-aspartic acid and Diabetic Glomerulosclerosis

ArticleYear
Cyclo-RGD Truncated Polymeric Nanoconstruct with Dendrimeric Templates for Targeted HDAC4 Gene Silencing in a Diabetic Nephropathy Mouse Model.
    Molecular pharmaceutics, 2021, 02-01, Volume: 18, Issue:2

    Topics: Animals; Dendrimers; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Drug Carriers; Drug Stability; Gene Silencing; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Kidney; Male; Mice; Nanoparticles; Oligopeptides; Peptides, Cyclic; Podocytes; Primary Cell Culture; Repressor Proteins; RNA, Small Interfering; Signal Transduction; Streptozocin

2021